Theodorus III

Theodorus Investment Funds, based in Brussels, Belgium, is a venture capital firm uniquely positioned as the investment arm for spin-offs originating from the Université Libre de Bruxelles (ULB). Established with the primary objective of fostering innovation and commercializing research breakthroughs from ULB, Theodorus plays a crucial role in bridging the gap between academic excellence and market viability. Their investment scope primarily targets early-stage and growth-stage companies emerging from the university's research ecosystem.

The firm's investment strategy is sector-agnostic within the ULB spin-off landscape, though it shows a strong inclination towards deep tech, life sciences (biotech, medtech, pharmaceuticals), and engineering sectors, reflecting ULB's research strengths. Theodorus provides not only capital but also strategic guidance and access to a network of experts, aiming to accelerate the development and market entry of these nascent companies. They are known for their hands-on approach, supporting founders through various stages of growth.

Theodorus typically makes initial investments ranging from $108,000 to $2,160,000, demonstrating a commitment to supporting companies from their very early stages. They are also prepared to provide follow-on funding, potentially investing up to $5,400,000 per company over its lifecycle, indicating a long-term partnership approach. Since its inception, Theodorus has made significant contributions to the Belgian innovation landscape, having invested in more than 30 companies and helping their portfolio companies collectively raise over $216 million in subsequent funding rounds. This track record underscores their vital role in transforming academic research into successful commercial ventures.